CHEK2 Gene Li-Fraumeni Syndrome Type 2 Genetic Test
Welcome to DNA Labs UAE, your trusted genetic lab for advanced DNA testing. In this blog post, we will discuss the CHEK2 Gene Li-Fraumeni Syndrome Type 2 Genetic Test, its cost, symptoms, diagnosis, and more.
Test Name: CHEK2 Gene Li-Fraumeni Syndrome Type 2 Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cancer
- Doctor: Oncologist
- Test Department: Genetics
Pre Test Information:
Before undergoing the CHEK2 Gene Li-Fraumeni Syndrome Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the CHEK2 Gene Li-Fraumeni Syndrome Type 2 NGS Genetic DNA Test gene CHEK2.
Test Details:
The CHEK2 gene is a tumor suppressor gene responsible for repairing damaged DNA. Mutations in this gene have been linked to an increased risk of developing various types of cancer, including breast, prostate, and colorectal cancer.
Li-Fraumeni syndrome is a rare inherited condition characterized by a high risk of developing multiple types of cancer at a young age. Type 2 Li-Fraumeni syndrome specifically refers to cases caused by mutations in the CHEK2 gene.
NGS (Next-Generation Sequencing) genetic testing is a cutting-edge method used to analyze the DNA sequence of multiple genes simultaneously. In the context of Li-Fraumeni syndrome type 2, NGS genetic testing can identify mutations in the CHEK2 gene that may increase an individual’s risk of developing cancer.
By identifying these mutations, individuals at high risk for Li-Fraumeni syndrome type 2 can undergo regular cancer screenings and take preventive measures to reduce their risk. These measures may include increased surveillance and risk-reducing surgeries.
It is important to note that genetic testing for Li-Fraumeni syndrome type 2 is typically recommended for individuals with a strong family history of cancer or those who have been diagnosed with certain types of cancer at a young age.
The decision to undergo genetic testing should be made in consultation with a healthcare professional or genetic counselor who can provide guidance and support.
At DNA Labs UAE, we prioritize accuracy, confidentiality, and personalized care. Our state-of-the-art NGS technology ensures reliable results, and our team of genetics experts is dedicated to helping you make informed decisions about your health.
For more information about the CHEK2 Gene Li-Fraumeni Syndrome Type 2 Genetic Test or to schedule an appointment, please contact our genetics department.
Test Name | CHEK2 Gene Li-Fraumeni syndrome type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CHEK2 Gene Li-Fraumeni syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CHEK2 Gene Li-Fraumeni syndrome type 2 NGS Genetic DNA Test gene CHEK2 |
Test Details |
The CHEK2 gene is a tumor suppressor gene that plays a role in repairing damaged DNA. Mutations in this gene have been associated with an increased risk of developing various types of cancer, including breast, prostate, and colorectal cancer. Li-Fraumeni syndrome is a rare inherited condition characterized by a high risk of developing multiple types of cancer at a young age. Type 2 Li-Fraumeni syndrome specifically refers to cases caused by mutations in the CHEK2 gene. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of multiple genes simultaneously. In the context of Li-Fraumeni syndrome type 2, NGS genetic testing can be used to identify mutations in the CHEK2 gene that may increase an individual’s risk of developing cancer. By identifying these mutations, individuals at high risk for Li-Fraumeni syndrome type 2 can undergo regular cancer screenings and take preventive measures to reduce their risk, such as increased surveillance and risk-reducing surgeries. It’s important to note that genetic testing for Li-Fraumeni syndrome type 2 is typically recommended for individuals with a strong family history of cancer or those who have already been diagnosed with certain types of cancer at a young age. The decision to undergo genetic testing should be made in consultation with a healthcare professional or genetic counselor who can provide guidance and support. |